TOLVAPTAN
tolvaptan 30 mg tablet, 28
TOLVAPTAN (12461W)
12461W
Body System:
Manner of administration:Oral
Restriction
Indication: Autosomal dominant polycystic kidney disease (ADPKD)
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 28 | # of repeats: 5 | DPMQ: $290.33 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Jinarc | |||||